(Date:11/4/2009)...g of Welfare Reform Rules Alter Longstanding Syste... Nov. 4 Current version...bills contain inadequate verification measures tha...from accessing taxpayer funded health benefits, ch...rm (FAIR). And in a radical change from current la...
(Date:11/4/2009)...t have a wider application, experts say , ...ug designed to treat patients with a rare form of ...haps replacing other anemia treatments that have b...nd stroke, experts say. , The drug, Hematide, w...ed-cell aplasia, a condition caused by antibodies ...
(Date:11/4/2009)...varix, it targets inside of virus, study shows , ... vaccine that targets human papillomavirus (HPV) i...rom progressing into full-blown malignancies, Dutc...ardasil and Cervarix -- have been approved for you...lso thought to spur precancerous lesions in the ce...
(Date:11/4/2009)...irstCall/ -- Qualsec (OTC Bulletin Board: QLSZ; Ge...Spice, LLC, announced that Dr Robi Ludwig, Psy.D.,...ing reporter has agreed to be a spokesperson for V...ehalf of VitaminSpice, on various media venues inc...alk Shows and satellite radio stations. ,, Dr ...
(Date:11/4/2009)...re-FirstCall/ -- Dialysis Corporation of America (...r the third quarter of 2009. ,, Quarter end ...ly Results included:, Operating revenues were ...me period last year, a 15% increase. Operating in... the same period last year, a 30% increase. Net ...
Breaking Medicine News(10 mins):Health News:Health Care Reform Legislation Becomes Vehicle for Reshaping Immigration Policy 2Health News:Health Care Reform Legislation Becomes Vehicle for Reshaping Immigration Policy 3Health News:Will New Anemia Drug Top Current Treatments? 2Health News:Will New Anemia Drug Top Current Treatments? 3Health News:New HPV Vaccine Might Stop Vulvar Cancer in its Tracks 2Health News:New HPV Vaccine Might Stop Vulvar Cancer in its Tracks 3Health News:Nationally Known Psychotherapist Dr. Robi Ludwig Joins Qualsec's Wholly-Owned Subsidiary VitaminSpice 2Health News:Dialysis Corporation of America Reports Third Quarter 2009 Results 2Health News:Dialysis Corporation of America Reports Third Quarter 2009 Results 3Health News:Dialysis Corporation of America Reports Third Quarter 2009 Results 4Health News:Dialysis Corporation of America Reports Third Quarter 2009 Results 5Health News:Dialysis Corporation of America Reports Third Quarter 2009 Results 6Health News:Dialysis Corporation of America Reports Third Quarter 2009 Results 7Health News:Dialysis Corporation of America Reports Third Quarter 2009 Results 8Health News:Dialysis Corporation of America Reports Third Quarter 2009 Results 9...BOR, Mich., Jan. 9 A study published today in The...e ( http://tinyurl.com/9x2ebc ),found that the mea...xpenditures, absence from the job, and short-term ...ease nephritis, as it,often is. That,s more than t...
...lease is available in French . , Scientists fr... Centre (MUHC) and the Douglas Mental Health Unive...s Top Ten Discoveries of 2008 for their groundbrea... of Medicine, Psychiatry; McGill Earth and Planeta...
...udents to benefit from program targeting kids in f...herent piece of the American dream -- that childre...heir parents -- is seriously at risk as the incide...rter lifespan than their parents. , , To address ...
...ng an average of 300 calories every day, study fin... If you,re like many Americans, soda and coffee dr...t the findings from a new study may make you drop ...e are now drinking almost 50 additional calories o...
...ord Springs Resort is ,Perfect Prescription, for W... Starting off the new year armed with knowledge ...s Wellness Weekend at the Omni Bedford Springs Re...l three-day event with a focus on women,s health, ...
...an. 9 The Society of Gynecologic Oncologists (SGO...cer, February 5-8, 2009 at the Henry B. Gonzalez C...,s meeting will feature more than 360 scientific p...treatment advances for physicians and health care ...
Other Medicine News:Health News:Lupus is a Significant Cost to Employers, According to Thomson Reuters Study 2Health News:Lupus is a Significant Cost to Employers, According to Thomson Reuters Study 3Health News:McGill, MUHC and Douglas researchers get top marks from Quebec Science magazine 2Health News:McGill, MUHC and Douglas researchers get top marks from Quebec Science magazine 3Health News:The Archdiocese of Philadelphia and Independence Blue Cross Team Up to Address Childhood Obesity 2Health News:The Archdiocese of Philadelphia and Independence Blue Cross Team Up to Address Childhood Obesity 3Health News:The Archdiocese of Philadelphia and Independence Blue Cross Team Up to Address Childhood Obesity 4Health News:Americans Consuming More Sugary Beverages 2Health News:Americans Consuming More Sugary Beverages 3Health News:Wellness and Pampering Highlight Women's Event, January 23-25 2Health News:Wellness and Pampering Highlight Women's Event, January 23-25 3Health News:Society of Gynecologic Oncologists to Host 40th Annual Meeting on Women's Cancer 2(Date:11/4/2009).../ -- According to Millennium Research Group (MRG),... intelligence, the European market for small-joint...hing almost $360 million. MRG,s European Markets ...port finds that as new product designs emerge and ...les and marketing, public awareness of the treatme...
(Date:11/4/2009)...RNewswire-FirstCall/ -- IPC The Hospitalist Compan...talist physician group practice company, announced...erating Officer, is scheduled to present on Wednes...uisse Health Care Conference in Phoenix, AZ. , , ...e Health Care Conference, Date...
(Date:11/4/2009)...re-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) ...c New Drug Application (NDA) with the U.S. Food an...rket pirfenidone for the treatment of patients wit...e has been granted Orphan Drug and Fast Track desi...an Drug status in Europe. ,, "IPF is a rapidly ...
Breaking Medicine Technology:European Small-Joint Reconstructive Implant Market to Nearly Double to $360 Million By 2014 2European Small-Joint Reconstructive Implant Market to Nearly Double to $360 Million By 2014 3IPC The Hospitalist Company, Inc. to Present at the 2009 Annual Credit Suisse Health Care Conference 2InterMune Announces Submission of NDA for Pirfenidone for the Treatment of Patients with IPF 2InterMune Announces Submission of NDA for Pirfenidone for the Treatment of Patients with IPF 3InterMune Announces Submission of NDA for Pirfenidone for the Treatment of Patients with IPF 4Anti Tumour Drug More Potent With Light Directed Delivery 13625 1Anti Tumour Drug More Potent With Light Directed Delivery 13625 2Analysis of Biofuels Indirect Land Use Effects Finds the Science Lacking 3A Too Diffuse and Subject To Too Many Arbitrary Assumptions To Be Useful for 13624 1Analysis of Biofuels Indirect Land Use Effects Finds the Science Lacking 3A Too Diffuse and Subject To Too Many Arbitrary Assumptions To Be Useful for 13624 2Analysis of Biofuels Indirect Land Use Effects Finds the Science Lacking 3A Too Diffuse and Subject To Too Many Arbitrary Assumptions To Be Useful for 13624 3Plasma protein Therapies Association Focuses Attention on Donors and Facilities 54825 1Plasma protein Therapies Association Focuses Attention on Donors and Facilities 54825 2Plasma protein Therapies Association Focuses Attention on Donors and Facilities 54825 3...E, N.M., Sept. 2 Clinical Lab,Products magazine f... http://www.biomoda.com ) and its proprietary earl...romising advances in the cancer diagnostic,technol.../www.clpmag.com/issues/articles/2008-08_01.asp ) m...t leads to large scale screening of lung,cancer us...
...ive Data Provide Initial Proof of Concept Across M...tal Setting Poster Presentation...: Dr. Mark Chan, MUNICH, Germany, Sept. 2 Regado...n of comprehensive results from Phase Ia, Ib,and I...stem at the European,Society of Cardiology,s Congr...
Other Medicine Technology:Clinical Lab Products Magazine Features Biomoda 2Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008 2Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008 3Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008 4Reference Lab Interface (RLI)©
...ng history of technology innovation, the new Guida...tion device on the VASOVIEW® platform. The ne...stem improves on a familiar platform, combining ea...flexibility and finesse into a proven system. Disc...
PM-8000 Express Patient Monitor
...ntains primers and a FAM-labeled probe that is des...In addition, this ASR contains primers, a Texas Re...quence. This ASR requires an instrument that can d...Cepheid SmartCycler System. The Cepheid Analyte Sp...
Medicine Products: